BioBridge Global Introduces BBG Advanced Therapies: New Subsidiary to Support the Development of Cell and Gene Therapies

Will Donors Return After Deferral: One Center’s Experience with Reinstatement After New FDA Guidance on Creutzfeldt-Jakob Disease